JP Morgan Chase’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.53M Sell
323,685
-13,921
-4% -$203K ﹤0.01% 3414
2025
Q4
$5.38M Sell
337,606
-195,684
-37% -$2.77M ﹤0.01% 3239
2025
Q3
$5.89M Buy
533,290
+94,941
+22% +$1.04M ﹤0.01% 3200
2025
Q2
$3.71M Sell
438,349
-263,153
-38% -$2.11M ﹤0.01% 3424
2025
Q1
$5.64M Sell
701,502
-225,796
-24% -$1.83M ﹤0.01% 3046
2024
Q4
$8.33M Buy
927,298
+424,482
+84% +$3.46M ﹤0.01% 2869
2024
Q3
$3.69M Sell
502,816
-4,218
-0.8% -$26.2K ﹤0.01% 3451
2024
Q2
$2.9M Buy
507,034
+199,103
+65% +$1.05M ﹤0.01% 3463
2024
Q1
$1.54M Buy
307,931
+88,828
+41% +$603K ﹤0.01% 4046
2023
Q4
$1.97M Sell
219,103
-9,416
-4% -$77.5K ﹤0.01% 3850
2023
Q3
$1.78M Sell
228,519
-163,899
-42% -$1.6M ﹤0.01% 3630
2023
Q2
$3.8M Buy
392,418
+180,476
+85% +$1.87M ﹤0.01% 3090
2023
Q1
$2.32M Buy
211,942
+70,932
+50% +$625K ﹤0.01% 3439
2022
Q4
$610K Buy
141,010
+65,446
+87% +$380K ﹤0.01% 4390
2022
Q3
$568K Buy
75,564
+3,290
+5% +$28.5K ﹤0.01% 4371
2022
Q2
$726K Buy
72,274
+64,649
+848% +$723K ﹤0.01% 4317
2022
Q1
$94K Buy
7,625
+4,114
+117% +$63.6K ﹤0.01% 5538
2021
Q4
$80K Sell
3,511
-2,499
-42% -$59.2K ﹤0.01% 5771
2021
Q3
$133K Sell
6,010
-85
-1% -$1.35K ﹤0.01% 5427
2021
Q2
$79K Buy
+6,095
New +$77.6K ﹤0.01% 5619
2021
Q1
Sell
-60
Closed -$1K 6055
2020
Q4
$1K Buy
+60
New +$873 ﹤0.01% 5541
2020
Q1
Sell
-4,000
Closed -$81K 5282
2019
Q4
$81K Buy
+4,000
New +$36.8K ﹤0.01% 4966

Other funds holding AUPH